Selventa CEO joins Swiss Institute of Bioinformatics
This article was originally published in Scrip
Executive Summary
David de Graaf, president and CEO of Selventa, a personalised healthcare company focused on developing personalised biomarker panels, has been appointed to the scientific advisory board of the Swiss Institute of Bioinformatics, along with Professor Alexey Nesvizhskii from the University of Michigan. The SIB is an academic, non-profit foundation established in 1988 to co-ordinate research and education in bioinformatics throughout Switzerland.